USD 29.1 billion
Report ID: SQMIG35I2254 | Region: Global | Published Date: February, 2024 | Pages: 242 | Tables: 124 | Figures: 76
Global Hospital-Acquired Infections Market size was valued at USD 29.1 billion in 2021 and is poised to grow from USD 29.54 billion in 2022 to USD 33.77 billion by 2030, growing at a CAGR of 1.5% in the forecast period (2023-2030).
Infections are mostly caused by microorganisms including viruses, bacteria, and fungus, as well as parasites. Infections can range from stomach and intestinal infections to lung and respiratory infections, eye and ear infections, hospital-acquired infections, skin infections, and sexually transmitted infections. Cross-infection from the surface and skin of the patient, equipment, and healthcare staff can result in hospital-acquired infections. Sterilization, cleaning and disinfection goods, protective barriers, and endoscope reprocessing items are among the several products and services available to control hospital-acquired infections.
Some of the primary drivers of this market are increased awareness of Hospital Acquired Infections (HAIs), the need to reduce cross infections, the incidence of infectious diseases in healthcare facilities, and supportive government measures to encourage infection control techniques. The implementation of infection prevention guidelines and policies at the hospital, regional, and national levels, as well as the increasing acceptance of monitoring technologies, are fueling growth.
US Hospital-Acquired Infections Market is poised to grow at a sustainable CAGR for the next forecast year.
Global Market Size
USD 29.1 billion
To get more reports on the above market click here to Buy The Report
The global Hospital-Acquired Infections market is segmented based on type, infection type, treatment, end user, and region. Based on Type, the Hospital-Acquired Infections market is segmented into Equipment (Sterilization Equipment, Disinfection Equipment), Services, Consumables (Disinfectants, Sterilization Consumables, Others). Based on Infection Type, the Hospital-Acquired Infections market is segmented into Bloodstream Infections, Ventilator-Associated Pneumonia (VAP), Urinary Tract Infection, Surgical-Site Infection, Gastrointestinal Infections, Others. Based on Treatment, the Hospital-Acquired Infections market is segmented into Antibacterial, Antiviral, Antifungal, Others. Based on End User, the Hospital-Acquired Infections market is segmented into Hospitals & Clinics, Ambulatory Surgical Centers, Others. Based on region, the Hospital-Acquired Infections market is categorized into North America, Europe, Asia-Pacific, and MEA.
Hospital-Acquired Infections Market Analysis by type
In 2021, Consumables segment dominated the market, accounting for 47.0% of total sales and is anticipated to maintain its dominance throughout the forecast period. This is due to the growing use of consumables in hospitals and ambulatory centers, as well as increased R&D spending by market participants. The COVID-19 pandemic was a significant factor to the consumables segment's dominance. Steris, for example, acquired Emergency Use Authorization (EUA) from the US FDA in April 2020 for respirator decontamination. This enabled the firm to provide a temporary solution for decontaminating compatible N95 or N95-equivalent respirators utilizing STERIS V-PRO Low Temperature Sterilization Systems.
Furthermore, the services segment is expected to have the highest CAGR of 5.2% over the forecast period. These include, among other things, disinfection-as-a-service, the design and execution of infection control strategies, and compliance software. The demand is likely to rise in the next years as a result of increased knowledge and favorable policies supported by government officials.
To get detailed analysis on other segments, Request For Sample Report
North America dominated the market in 2021, accounting for more than 34.0% of total sales. The substantial share can be due to the presence of key players, activities implemented by them in the public and commercial sectors, and increased awareness of HAIs in this region. For example, in December 2020, Ecolab, headquartered in the United States, acquired vanBaerle Hygiene AG in Switzerland. This expanded Ecolab's product line and service capabilities to include a comprehensive spectrum of cleaning, disinfection, and hygiene solutions.
The Asia Pacific market is expected to grow at the fastest rate of 5.7% over the next five years. This is due to an increase in the prevalence of hospital-acquired illnesses and the development of healthcare infrastructure in poor and middle-income countries. The World Health Organization (WHO) reports that the frequency of ICU-acquired infection is two to three times greater in low- and middle-income countries than in high-income nations. Whereas in the United States, device-associated infections are almost 13 times higher. Furthermore, babies in developing nations are more likely than those in high-income countries to suffer healthcare-associated illnesses. According to the WHO, infection rates are 3 to 20 times greater. This is likely to boost market growth, particularly in Latin America, the Middle East, and Africa.
To know more about the market opportunities by region and country, click here to
Buy The Complete Report
Hospital-Acquired Infections Market Driver
The number of surgical procedures performed worldwide has increased significantly throughout the years. Every year, around 235 million major surgical procedures are conducted worldwide, according to the WHO (2019). This is due to the rising frequency of obesity and other lifestyle disorders, an aging population, and an increase in spine injuries and sports-related injuries. As the number of surgical procedures performed grows, so does the demand for various surgical equipment and medical gadgets. Because of the demonstrated benefits of sterilized items and increased awareness about their usefulness in healthcare settings, this is projected to stimulate demand for hospital acquired infection services.
Hospital-Acquired Infections Market Restraint
Reprocessing reusable medical devices helps healthcare providers save money and reduce waste. Surgical forceps, endoscopes, and stethoscopes are all examples of reusable medical devices. However, there are questions about recycled gadgets' safety and performance. Inadequate instrument cleaning and sterilization can cause the retention of blood, tissue, and other biological waste in reusable devices, increasing the risk of surgical-site infections (SSIs) in patients. The debris may enable microorganisms to survive the subsequent disinfection or sterilization process, potentially leading to HAIs. Inadequate reprocessing can potentially cause tissue irritation from remaining reprocessing materials like chemical disinfectants. These concerns are limiting hospital administrators and clinicians' acceptance of reprocessing.
Speak to one of our ABIRAW analyst for your custom requirements before the purchase of this report
The market for hospital acquired infection control is highly competitive. Market participants are launching strategic activities such as customer acquisition, strategic collaborations, distribution network strengthening, and R&D. Key firms are also diversifying their portfolios and investing in new technologies to boost their market share. Steris, for example, expanded its offerings by acquiring Cantel Medical, a significant producer of infection prevention products and services, in June 2021.
Hospital-Acquired Infections Market Top Player’s Company Profiles
Hospital-Acquired Infections Market Recent Development
SkyQuest’s ABIRAW (Advanced Business Intelligence, Research & Analysis Wing) is our business information services team that collects, collates, co-relates, and analyses the data collected by means of primary exploratory research backed by the robust secondary desk research.
According to our analysis, the presence of numerous microorganisms producing infections in healthcare facility centers, as well as an increase in the prevalence of hospital-acquired illnesses, are expected to drive the worldwide hospital-acquired infections treatment market growth during the forecast period. Along with this rising awareness by many government organizations and key players to educate people about emerging infections acquired during hospital admission, symptoms associated with it, and available treatment options, the hospital-acquired infections treatment market is expected to grow during the forecast period. However, in low-middle income countries, poor healthcare infrastructure and a lack of educational training in infection control are projected to stymie market expansion for hospital-acquired infections therapy during the forecast period.
|Market size value in 2021
|USD 29.1 billion
|Market size value in 2030
|USD 33.77 billion
|Forecast Unit (Value)
|North America (US, Canada), Europe (Germany, France, United Kingdom, Italy, Spain, Rest of Europe), Asia Pacific (China, India, Japan, Rest of Asia-Pacific), Latin America (Brazil, Rest of Latin America), Middle East & Africa (South Africa, GCC Countries, Rest of MEA)
Free report customization with purchase. Customization includes:-
To get a free trial access to our platform which is a one stop solution for all your data requirements for quicker decision making. This platform allows you to compare markets, competitors who are prominent in the market, and mega trends that are influencing the dynamics in the market. Also, get access to detailed SkyQuest exclusive matrix.
Buy The Complete Report to read the analyzed strategies adopted by the top vendors either to retain or gain market share
Parent Market Analysis
KEY MARKET INSIGHTS
MARKET DYNAMICS & OUTLOOK
Market Size by Region
KEY COMPANY PROFILES
For the Global Hospital-Acquired Infections Market, our research methodology involved a mixture of primary and secondary data sources. Key steps involved in the research process are listed below:
1. Information Procurement: This stage involved the procurement of Market data or related information via primary and secondary sources. The various secondary sources used included various company websites, annual reports, trade databases, and paid databases such as Hoover's, Bloomberg Business, Factiva, and Avention. Our team did 45 primary interactions Globally which included several stakeholders such as manufacturers, customers, key opinion leaders, etc. Overall, information procurement was one of the most extensive stages in our research process.
2. Information Analysis: This step involved triangulation of data through bottom-up and top-down approaches to estimate and validate the total size and future estimate of the Global Hospital-Acquired Infections Market.
3. Report Formulation: The final step entailed the placement of data points in appropriate Market spaces in an attempt to deduce viable conclusions.
4. Validation & Publishing: Validation is the most important step in the process. Validation & re-validation via an intricately designed process helped us finalize data points to be used for final calculations. The final Market estimates and forecasts were then aligned and sent to our panel of industry experts for validation of data. Once the validation was done the report was sent to our Quality Assurance team to ensure adherence to style guides, consistency & design.
With the given market data, our dedicated team of analysts can offer you the following customization options are available for the Global Hospital-Acquired Infections Market:
Product Analysis: Product matrix, which offers a detailed comparison of the product portfolio of companies.
Regional Analysis: Further analysis of the Global Hospital-Acquired Infections Market for additional countries.
Competitive Analysis: Detailed analysis and profiling of additional Market players & comparative analysis of competitive products.
Go to Market Strategy: Find the high-growth channels to invest your marketing efforts and increase your customer base.
Innovation Mapping: Identify racial solutions and innovation, connected to deep ecosystems of innovators, start-ups, academics, and strategic partners.
Category Intelligence: Customized intelligence that is relevant to their supply Markets will enable them to make smarter sourcing decisions and improve their category management.
Public Company Transcript Analysis: To improve the investment performance by generating new alpha and making better-informed decisions.
Social Media Listening: To analyze the conversations and trends happening not just around your brand, but around your industry as a whole, and use those insights to make better Marketing decisions.
Want to customize this report? This report can be personalized according to your needs. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time. We offer $1000 worth of FREE customization at the time of purchase.
"We have purchased recently a report from SkyQuest Technology, and we are happy to inform you that this report was so useful and practical for our team. Skyquest Team was very active and our queries were followed up completely.It was amazing. "
- Mr. Ali Zali, Commercial Director, ICIIC Iran.